Literature DB >> 12661821

Routine hepatitis B immunization in India: cost effectiveness needs reassessment.

Jacob M Puliyel, Riju Mittal, Vineet Tyagi, Sangeeta Gupta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12661821     DOI: 10.1007/BF02723756

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.

Authors:  M A Miller; L McCann
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

2.  Routine hepatitis B immunisation in India: cost-effectiveness assessment.

Authors:  M A Miller; M Kane
Journal:  Indian J Pediatr       Date:  2000-04       Impact factor: 1.967

Review 3.  Immunizations: current recommendations.

Authors:  S B Adkins
Journal:  Am Fam Physician       Date:  1997-09-01       Impact factor: 3.292

Review 4.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

5.  Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study.

Authors:  K Sakuma; N Saitoh; M Kasai; H Jitsukawa; I Yoshino; M Yamaguchi; K Nobutomo; M Yamumi; F Tsuda; T Komazawa
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

6.  Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.

Authors:  B J McMahon; S R Alberts; R B Wainwright; L Bulkow; A P Lanier
Journal:  Arch Intern Med       Date:  1990-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.